Formulation: A 1 mg/ml solution in methyl acetate
Purity: ≥97%
- 8-epi PGA1
- 8-iso PGA1
Formulation: A 1 mg/ml solution in methyl acetate
Purity: ≥98%
- A2 Isoprostane
- 15-A2t-IsoP
- 15-A2t-Isoprostane
- 8-epi PGA2
- 8-iso PGA2
8-
An isoprostane that inhibits platelet aggregation
CAS No. 27415-26-5
Item No. 16350
Formulation: A crystalline solid
Purity: ≥98%
- iPF2α-III
- 8-iso-15(S)-Prostaglandin F2α
- 8-Isoprostane
- 8-epi PGF2α
- 15-F2t-Isoprostane
Formulation: A crystalline solid
Purity: ≥98%
- 8-epi PGE1
- 8-iso PGE1
- Ovinonic Acid
Formulation: A crystalline solid
Purity: ≥99%
- 8-epi-9β-PGF1α
- 8-iso PGF1β
8-
An internal standard for the quantification of 8-
CAS No. 211105-40-7
Item No. 316350
Formulation: A 100 µg/ml solution in methyl acetate
Purity: ≥99% deuterated forms (d1-d4)
- iPF2α-
III- d4 - 8-
Isoprostane- d4 - 15-
F2t- Isoprostane- d4 - 8-
epi PGF2α- d4
Formulation: A 100 µg/ml solution in acetonitrile
Purity: ≥98%
- ent-8-epi PGF2α-d9
- ent-8-iso PGF2α-d9
- ent-15-F2t-Isoprostane-d9
8-iso-13,14-
An 8-isoprostane metabolite
CAS No. 191919-02-5
Item No. 16380
Formulation: A 500 µg/ml solution in methyl acetate
Purity: ≥98%
- 8-iso-13,14-dihydro-15-keto PGF2α
Formulation: A crystalline solid
Purity: ≥99%
- 8-epi PGF1α
- 8-iso PGF1α
8,12-
An isoprostane used as a biomarker for oxidative stress
CAS No. 1445349-99-4
Item No. 16310
Formulation: A 100 µg/ml solution in acetonitrile
Purity: ≥95%
- 8,12-iso-Isoprostane-F2α-VI
- 12-iso-5,6E,14Z-PGF2α
- 12-
iso- 5,6E,14Z- Prostaglandin F2α
8,12-
A deuterated internal standard for a predominant isoprostane isomer
CAS No. 1616977-85-5
Item No. 10006878
Formulation: A 50 µg/ml solution in acetonitrile
Purity: ≥99% deuterated forms (d1-d11)
- 8,12-iso-Isoprostane-F2α-VI-d11
- 12-iso-5,6E,14Z-PGF2α-d11
- 12-iso-5,6E,14Z-Prostaglandin F2α-d11
8-iso Prostaglandin E2
An isoprostane with renal vasoconstrictor and anti-
CAS No. 27415-25-4
Item No. 14350
Formulation: A crystalline solid
Purity: ≥99%
- 8-iso PGE2
- 8-epi PGE2
A1-
An isoprostane formed from α-
CAS No. 1035557-09-5
Item No. 9000593
Formulation: A 1 mg/ml solution in methyl acetate
Purity: ≥90% (trans isomer mix)
- 16-
A1- Phytoprostane - Phytoprostane A1
- PPA1
8-iso Prostaglandin F3α
An isoprostane produced from the free-radical peroxidation of EPA
CAS No. 7045-31-0
Item No. 16992
Formulation: A 100 µg/ml solution in methyl acetate
Purity: ≥98%
- 8-epi PGF3α
- 8-iso PGF3α
ent-
A vasoconstrictor and inhibitor of platelet aggregation
CAS No. 214748-66-0
Item No. 10010380
Formulation: A 100 µg/ml solution in acetonitrile
Purity: ≥98%
- ent-15-epi-F2t-Isoprostane
- ent-8-iso-15-epi-PGF2α
ent-8-iso-15(S)-Prostaglandin F2α-
An internal standard for the quantification of ent-8-iso-15(S)-PGF2α
Item No. 10011720
Formulation: A 50 µg/ml solution in acetonitrile
Purity: ≥99% deuterated forms (d1-d9)
- ent-8-iso-
PGF2α-d9 - ent-15-epi-F2t-Isoprostane-d9
Formulation: A 100 µg/ml solution in ethanol
Purity: ≥95%
- iPF2α-
I - Isoprostane F2α-I
- 5-iso PGF2α-VI
- 5-iso Prostaglandin F2α-VI
8-
A peroxidative decomposition product of anandamide
Item No. 10005764
Formulation: A 1 mg/ml solution in ethanol
Purity: ≥98%
- iPF2α-III Ethanolamide
- 8-Isoprostane Ethanolamide
- 8-iso PGF2α Ethanolamide
- 8-epi PGF2α Ethanolamide
ent-8-iso Prostaglandin F2α-d9
An internal standard for the quantification of ent-8-iso-prostaglandin F2α
Item No. 10011721
Formulation: A 100 µg/ml solution in acetonitrile
Purity: ≥99% deuterated forms (d1-d9)
- ent-8-epi PGF2α-
d9 - ent-8-iso PGF2α-
d9 - ent-15-F2t-Isoprostane-d9
2,3-dinor-8-
An active metabolite of arachidonic acid and 8-iso PGF2α
CAS No. 221664-04-6
Item No. 15290
Formulation: A 100 µg/ml solution in methyl acetate
Purity: ≥98%
- 2,3-dinor-5,6-dihydro-15-F2t-IsoP
- 2,3-dinor-5,6-dihydro-15-F2t-Isoprostane
- 2,3-dinor-iPF1α-III
- 2,3-dinor-8-iso PGF1α
(±)5-
An internal standard for the quantification of (±)5-
CAS No. 936565-17-2
Item No. 10006654
Formulation: A 100 µg/ml solution in ethanol
Purity: ≥99% deuterated forms (d1-d11)
Formulation: A 100 µg/ml solution in methyl acetate
Purity: ≥95%
- 2,3-dinor-iPF2α-III
- 2,3-dinor-8-iso PGF2α
Formulation: A 1 mg/ml solution in methyl acetate
Purity: ≥98%
- ent-PGE2
8-
An internal standard for the quantification of 8-
Item No. 10008935
Formulation: A 100 µg/ml solution in methyl acetate
Purity: ≥99% deuterated forms (d1-d9)
- 8-epi PGF1α-d9
- 8-iso PGF1α-d9
8-iso-15-
A metabolite of 8-iso PGF2α with vasoconstrictor activity
CAS No. 191919-01-4
Item No. 16390
Formulation: A 1 mg/ml solution in methyl acetate
Purity: ≥95%
- 8-
epi- 15- keto PGF2α - 8-
iso- 15- keto PGF2α
Contact Info
Cayman Chemical1180 East Ellsworth RoadAnn Arbor, Michigan 48108 USAToll Free: (800) 364-9897(USA and Canada only)Fax: (734) 971-3640
